期刊文献+

胶质瘤干细胞与神经干细胞基因表达差异的微阵列基因芯片分析 被引量:7

Identification of the difference in gene expression between glioma stem cells and neural stem cells by oligonucleotide microarray
下载PDF
导出
摘要 目的利用基因芯片技术筛选人脑胶质瘤干细胞(GSCs)和正常神经干细胞(NSCs)中差异表达的基因。方法利用人类HOA5.1 OneArray表达谱芯片(包括29 186个基因),与GSCs和NSCs的总RNA生成的探针进行杂交,通过寡核苷酸芯片ScanArray 4000筛选两者之间的差异基因,并选择其中的部分差异表达基因(DCX、PTGS2、SCGN、GAD2、OTX2、PEG10、NRXN3)进一步行qRT-PCR验证。结果与正常NSCs相比,GSCs中1372个基因表达下调,1501个基因表达上调,功能富集分析显示,这些差异基因主要参与了神经轴突导向、细胞周期、细胞黏附、免疫炎症反应及癌症相关的信号路径。qRT-PCR检测结果与芯片检测结果相符。结论多类基因在胶质瘤的发生发展中发挥着重要作用,该结果可为胶质瘤的靶向治疗提供新的线索。 Objective To identify the differential expressed genes of human glioma stem cells(GSCs) and human neural stem cells(NSCs) by gene chip technology. Methods Human HOA5.1 OneArray microarray(including 29 186 genes) was adopted and hybridized with probes which were prepared from the total RNAs of GSCs and NSCs. Differential expressed genes between the GSCs and NSCs were assayed after scanning oligonucleotide microarray with ScanArray 4000, and some of these genes such as DCX, PTGS2, SCGN, GAD2, OTX2, PEG10 and NRXN3 were verified by real-time-Q-PCR method. Results Compared with the genes in normal NSCs, 1372 down-regulated and 1501 up-regulated genes in GSCs were revealed by means of microarray, and these genes were associated with axon guidance, cell cycle, cell adhesion, immune-inflammatory responses and cancer-related signal pathways. The results of qRT-PCR were consistent with that of microarray. Conclusions Multiple genes play important roles in development of glioma. This study may provide new clues for the targeted therapy of malignant glioma.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2014年第10期800-803,共4页 Medical Journal of Chinese People's Liberation Army
关键词 神经胶质瘤 肿瘤干细胞 神经干细胞 寡核苷酸序列分析 glioma tumor stem cells neural stem cells oligonucleotide array sequence analysis
  • 相关文献

参考文献15

  • 1Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: genetics and biology of a grave matter[J]. Genes Dev, 2001, 15(11): 1311-1333.
  • 2Rich JN. Cancer stem cells in radiation resistance[J]. Cancer Res, 2007, 67(19): 8980-8984.
  • 3Singh SK, Hawkins C, Clarke ID: et al. Identification of human brain tumour initiating cells[J]. Nature, 2004, 432(7015): 396-401.
  • 4Galli R, Binda E, Orfanelli 13, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma[J]. Cancer Res, 2004, 64( 19): 7011-7021.
  • 5Dean M, Fojo T, Bates S. Tumour stem ceils and drug resistance [J]. Nat Rev Cancer, 2005, 5(4): 275-284.
  • 6Q uinones-Hinojosa A, Chaichana K. The human subventricular zone: a source of new cells and a potential source of brain tumors[J]. Exp Neurol, 2007, 205 (2): 313-324.
  • 7Chaichana KL, Guerrero-Cazares H, Capilla-Gonzalez V, et al.Intra-operatively obtained human tissue: protocols and techniques for the study of neural stem cells[J]. J Neurosci Methods: 2009, 180(1): 116-125.
  • 8Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells [J]. Cancer Cell, 2007, 11 ( 1): 69-82.
  • 9Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas[J]. Proc Natl Acad Sci USA, 2000, 97(23): 12846-12851.
  • 10Alcantara Llaguno S, Chen J, Kwon CH, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model[J]. Cancer Cell, 2009, 15(1): 45-56.

同被引文献101

  • 1范存刚,张庆俊.肿瘤坏死因子相关凋亡诱导配体治疗脑胶质瘤的研究进展[J].肿瘤防治研究,2014,41(2):168-172. 被引量:7
  • 2易伟,牛洪泉,陶胜忠,叶飞,雷霆,薛德麟.人脑胶质瘤细胞的原代培养及生长活性观察[J].中华神经外科疾病研究杂志,2005,4(3):245-247. 被引量:9
  • 3姜政,江玉泉,李新钢,李冰,周伟.人脑胶质瘤细胞原代培养实验模型的构建[J].中华肿瘤防治杂志,2006,13(10):744-747. 被引量:14
  • 4Salgaller ML, Liau LM. Current status of clinical trials for glioblastoma [J]. Rev Recent Clin Trials, 2006, 1 (3): 265-281.
  • 5Chamberlain MC. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas [J]. Expert Rev Neurother, 2010, 10 (10): 1537-1544.
  • 6Kang SK, Park JB, Cha SH. Multipotent, dedifferentiated cancer stem-like cells from brain gtiomas [J]. Stem Cells Dev, 2006, 15 (3): 423-435.
  • 7Cheng L, Bao S, Rich JN. Potential therapeutic implications of cancer stem cells in glioblastoma [J]. Biochem Pharmacol, 2010, 80 (5): 654-665.
  • 8Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs orenzyme inhibitors [J]. Adv Enzyme Reg, 1984, 22: 27-55.
  • 9Yoshimoto K, Ma X, Guan Y, et al. Expression of stem cell marker and receptor kinase genes in glJoblastoma tissue quantified by real-time RT-PCR [J]. Brain Tumor Pathol, 2011, 28 (4): 291-296.
  • 10DasS, Srikanth M, Kessler JA. Cancer stem cells and glioma [J]. Nat Clin Pract Neurol, 2008, 4 (8): 427-435.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部